Market Research Report

A quick peek into the report

Global Precision Psychiatry Market

Focus on Product Type, Biomarker, Sample, Technology, Applications, End Users, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2021-2026

Some Faq's

Frequently Asked Questions

The precision psychiatry market was estimated at $643.6 Million in 2020 and is expected to grow at a CAGR of 17.26% during the forecast period, 2021-2026.

Possible opportunities that can boost the growth include increased use of precision diagnostics for drug development by pharmaceutical and companion diagnostics companies.

Factors driving the growth of the market include decreasing cost of sequencing and increasing adoption of inorganic growth strategies.

Applications for which precision psychiatry can be used include alzheimer’s, parkinson’s, autism, depression, bipolar disease, and other disorders.

Key companies operating in the market include Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, ARUP Laboratories, Invitae Corporation, OPKO Health, Inc., Laboratory Corporation of America Holdings, Centogene N.V., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Konica Minolta, Inc., Fulgent Genetics, PreventionGenetics

Similar Product

You may also like

Global Pharmacogenomics Market
Published Year: 2019

Global Pharmacogenomics Market: Focus on Services, Applications, Technologies, End Users, Country Da

The global pharmacogenomics market has been witnessing a steady growth since the end of the...

Global Molecular Diagnostics Market
Published Year: 2019

Global Molecular Diagnostics Market: Focus on Product Type (Kits and Consumables, Systems, Software

The global molecular diagnostics market has been witnessing a steady growth since the end of...